GHRP-2 5mg — 5mg penGHRP-2 5mg
Quality
Pharmacy grade
Form
Pen with case
Level
any
Consultation required · prescriber

GHRP-2 5mg

GHRP-2 5mg in a branded pre-filled pen with case, available only following an online consultation and clinician approval.

£19/ 5mg pen
Available after consultation
GHRP-2 5mg
£19
Start consultation

Answer a short online consultation. A clinician reviews it, and you only pay if treatment is approved. Dispensed by our licensed facility.

GHRP-2, also known as pralmorelin, is a synthetic growth hormone releasing peptide studied for its effects on hormone signalling. Welcuren offers a doctor and consultant-led assessment for adults seeking an informed discussion about its evidence, uncertainties and individual suitability.
Strength
5mg
Form
Pen with case
Supplied by
Licensed facility

What it is

GHRP-2 acts at the ghrelin receptor, which is involved in appetite and growth hormone signalling. A measurable hormonal response does not, by itself, demonstrate a health or wellbeing benefit.

The 5mg presentation is supplied as a branded pre-filled pen with case through our licensed facility, only after an online consultation, a prescription and clinician approval. GHRP-2 is not a UK-licensed medicine; facility licensing is separate from a medicine’s marketing authorisation.

Why people ask about it

People may ask about GHRP-2 after encountering discussions about ageing, exercise recovery, sleep or body composition. These are reasons for interest, rather than established outcomes of its use.

Our clinicians provide a measured discussion of the available evidence and its limitations. A consultation does not guarantee a prescription, and established alternatives may be more appropriate.

What the science says

Published research includes small, short-duration human studies of hormone secretion and appetite, as well as laboratory and animal work. Much of this evidence concerns biological responses rather than sustained, patient-relevant outcomes.

There is insufficient high-quality evidence to support GHRP-2 for longevity or general wellness. Findings from individual studies cannot establish the effectiveness or long-term safety of this specific pre-filled pen presentation.

How Welcuren works

Complete a short online consultation about your health and goals.

A clinician reviews your answers, may ask follow-up questions, and decides whether this treatment is appropriate for you.

You only pay once treatment is approved. Our licensed facility then dispatches it with full instructions, on tracked global delivery.

Safety

Possible adverse effects include increased appetite, flushing, headache, dizziness and fluid retention. Changes in glucose regulation and other hormone levels, including cortisol and prolactin, are also concerns. The frequency and significance of these effects during longer-term use are not well established.

Clinicians determine whether baseline assessment, blood tests and follow-up monitoring are appropriate. Monitoring cannot eliminate risk or resolve gaps in the evidence. Any new or concerning symptoms should be discussed promptly with the clinical team.

Questions

Is GHRP-2 licensed in the UK?

GHRP-2 is not a UK-licensed medicine. Supply through our licensed facility does not mean the product has a UK marketing authorisation. Clinicians explain its status and the implications before any prescribing decision.

Does GHRP-2 have established longevity benefits?

No robust clinical evidence establishes a longevity benefit. Short-term changes in hormone levels should not be interpreted as evidence of longer life or improved long-term health.

What is supplied if prescribing is approved?

The GHRP-2 5mg presentation is supplied as a branded pre-filled pen with case. Access requires an online consultation, a prescription and clinician approval; approval is not automatic.

What will clinicians review during the consultation?

Clinicians review your goals, medical history, medicines and relevant health information. They discuss evidence limitations, licensing status, possible adverse effects and whether further assessment or an alternative approach is more appropriate.

This information is educational and not a substitute for advice from your clinician. Prescription treatments are only supplied after a clinical consultation.

Often considered together

Many clients start with a blood test so their clinician has a full picture.

AOD-9604 5mgAOD-9604 5mg

AOD-9604 5mg

AOD-9604 5mg is supplied in a branded pre-filled pen with case, available only following an online consultation and clinician approval.

5mg pen
CJC-1295 + Ipamorelin BlendCJC-1295 + Ipamorelin Blend

CJC-1295 + Ipamorelin Blend

A dual-secretagogue blend with uncertain formulation and no robust clinical evidence for the marketed combination.

Component quantities and DAC status not specified
CJC-1295 No DAC 5mgCJC-1295 No DAC 5mg

CJC-1295 No DAC 5mg

A label commonly used for modified GRF(1–29), distinct from the albumin-binding CJC-1295 studied in published trials.

5mg